Dr. Christopher L. Steele, MD

Dr. Steele practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Dr. Steele's NPI, 1922492255, was assigned on March 25, 2015. Dr. Steele graduated from University of Connecticut School of Medicine in 2015. Dr. Steele holds Connecticut license 057260.

Dr. Steele's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Dr. Steele's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Steele is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group. Dmand AI also links Dr. Steele to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steele practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Steele's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Steele is licensed in Connecticut.

CMS data shows 278 Medicare services from Dr. Steele across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $20,521 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Steele in 2024. The largest group is 75 to 84, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Steele's median patient age at 75, with 50% women.

In 2024, Dr. Steele wrote 91 Medicare Part D claims for 37 patients. 78% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $96 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Steele accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Steele, published from 2019 to 2025. 2025 was the busiest year, with 2. Dr. Steele has published most often in J Gen Intern Med. Dr. Steele's most frequent co-authors are Danelle Olson Cayea, MD and Maura J. McGuire, MD.

CMS Open Payments shows 5 general payments to Dr. Steele from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 80% of the total. Abbott Laboratories paid the most, $22.

Dr. Steele graduated from University of Connecticut School of Medicine in 2015.